Small-Molecule Glycoprotein IIb/IIIa Inhibitors as Adjunctive Therapy in Percutaneous Coronary Interventions
Oral Platelet IIb/IIIa Inhibitors
Left Circumflex Occlusion—Underrecognized and Undertreated
Association of Endogenous Tissue Plasminogen Activator (t-PA) with Clinical Characteristics of the Insulin Resistance Syndrome
Argatroban and Alteplase in Patients with Acute Myocardial Infarction
The TETAMI Trial
Impaired Culprit Vessel Flow in Acute Coronary Syndromes Ineligible for Thrombolysis
Activation of Blood Platelets after Percutaneous Transluminal Coronary Angioplasty and Coronary Artery Bypass Graft Surgery
Ticlopidine and Aspirin Fail to Suppress the Increased Platelet Aggregability That Follows Percutaneous Coronary Interventions
The Treatment and Outcome of Cancer Patients with Thromboses on Central Venous Catheters
The Antithrombotic Effects of CI-1028, an Orally Bioavailable Direct Thrombin Inhibitor, in a Canine Model of Venous and Arterial Thrombosis
Intramyocardial Injection of DNA Encoding Vascular Endothelial Growth Factor in a Myocardial Infarction Model